ResearchUsing Federal, State, and Grassroots Advocacy to Effect Change in Cancer Care Delivery and Patient Outcomes in the United States
ResearchRadiotherapy Combined with Nivolumab or Temozolomide for Newly Diagnosed Glioblastoma with Unmethylated MGMT Promoter: An International Randomized Phase III Trial
ResearchCapicua (CIC) Mutations in Gliomas in Association with MAPK Activation for Exposing a Potential Therapeutic Target
ResearchClinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
ResearchMolecular Alterations Associated with Improved Outcome in Patients with Glioblastoma Treated with Tumor-Treating Fields
ResearchSurvivorship Care Plans Improve the Identification of Post-radiation Hypothyroidism After Head and Neck Cancer Treatment
ResearchPhase III Trial of Chemoradiotherapy with Temozolomide Plus Nivolumab or Placebo for Newly Diagnosed Glioblastoma with Methylated MGMT Promoter
ResearchVolumetric Modulated Arc Therapy (VMAT) Craniospinal Irradiation (CSI) for Children and Adults: A Practical Guide for Implementation
ResearchPattern of Distant Metastasis in Oropharyngeal Carcinoma — Do They Differ by HPV Status? [Letter]